This document discusses a new pharmaceutical platform called Hyronex, which is a sodium hyarulnate injection used to treat joint pain. It provides information on the product, including its dosage, packaging, and price. Tables show market share and sales values for various pain medications, with sodium hyarulnate injection sales decreasing nearly 50% recently. The document also lists strengths and weaknesses of the pharmaceutical industry in Bangladesh and factors that could impact the domestic market. Diagrams depict different strategies that companies may employ to create value beyond just lowering costs.